New Delhi, Aug. 1 -- Micro-cap pharma stock Balaxi Pharmaceuticals' share price traded on a firm note on Friday, August 1, despite weakness in the Indian stock market. The stock, with a market capitalisation of just Rs.84 crore, rebounded from its 52-week low of Rs.46.19 apiece hit in the previous trading session (July 31).

The NSE-listed pharma stock gained nearly 1% to hit the day's high of Rs.48.35. However, the stock still trades at a one-third value of its 52-week high of Rs.129.44, scaled a year-ago.

On the financial front, the micro-cap pharma stock has scripted a sharp turnaround, swinging from losses in financial year 2023-24 (FY24) to a profit in FY25, supported by a growth in its revenue.

Its revenue saw a 21% year-on-year (...